Types of Cancer We Treat

Ovarian Cancer

Our gynecologic oncologists diagnose ovarian cancer and treat it using the latest surgical procedures, including minimally invasive, robotic-assisted, and fertility-sparing approaches and clinical trials.

Our gynecologic oncologists, genetic counselors, and fertility specialists offer services for women at an increased genetic risk of developing ovarian cancer. Our experts help you carefully consider whether screening or risk-reduction surgery is right for you.

We understand how important quick decisions are in treating ovarian cancer, so we generally see you within 48 hours of your appointment request. We complement cancer care with support services, including integrative health therapies, psychological support, genetic testing, and survivorship plans.

Find a Doctor & Schedule
Diagnosis
Surgery
Fertility-Sparing Procedures
Chemotherapy & Targeted Drugs

Related News

Birth Control Pills May Protect Against Gynecologic Cancers
Read Story
Gynecologic Cancers Not Tied to Higher COVID-19 Death Risk
Read Story
Many Ovarian Tumors May Originate in Two Cell Types
Read Story
New Treatment for Advanced Ovarian Cancer Shows Promise
Read Story
What You Need to Know About Treating Ovarian Cancer
Read Story
Managing the Side Effects of Chemotherapy for Ovarian Cancer
Read Story
Using Biomarkers to Guide Ovarian Cancer Treatment Decisions
Read Story
Many Pelvic Tumors in Women Start in Fallopian Tubes
Read Story
Changes in Gene Contribute Independently to Cancer Risk
Read Story
New Pathway for Stalling BRCA Tumor Growth Revealed
Read Story

Clinical Trials and Research Studies

Phase 1

A Phase 1b First-in-Human Dose Escalation and Expansion Study of XMT-1536 In Patients with Solid Tumors Likely to Express NaPi2b

Learn More

Phase 5

A Phase 1-2 First-in-Human Study of CX-2029 in Adults with Metastatic or Locally Advanced Unresectable Solid Tumors or Lymphomas.

Learn More

Phase 5

A MULTI-CENTER OPEN LABEL PHASE 1/2 STUDY OF CYT-0851 AN ORAL RAD51 INHIBITOR IN PATIENTS WITH RELAPSED/REFRACTORY B-CELL MALIGNANCIES AND ADVANCED SOLID TUMORS

Learn More

Phase 2

A Phase 1b/2 Open-Label Study to Evaluate the Safety and Efficacy of Lucitanib in Combination with Nivolumab in Patients with an Advanced Metastatic Solid Tumor

Learn More
View All Related Clinical Trials (7)